ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 20 Issue : 4
Current Issue Archive Popular Article Ahead of Print

   
Quick Search





 
Catalpol pretreatment attenuates cardiac dysfunction following myocardial infarction in rats [Anatol J Cardiol]
Anatol J Cardiol. 2018; 19(5): 296-302 | DOI: 10.14744/AnatolJCardiol.2018.33230  

Catalpol pretreatment attenuates cardiac dysfunction following myocardial infarction in rats

Fangjie Bi1, Yujia Xu2, Quansan Sun3
1Department of Cardiology, Zibo Central Hospital; Shandong-China
2Department of Echocardiography, Linzi District Hospital; Shandong-China
3Linzi Qidu Hospital; Shandong-China

Objective: To investigate the effects and mechanisms of catalpol on cardiac function in rats with isoproterenol (ISO)-induced myocardial infarction (MI).
Methods: Adult male Wistar rats were divided into four groups: control group, ISO group, catalpol (L, low dose) group, and catalpol (H, high dose) group. Isoproterenol (85 mg/kg) was injected subcutaneously for 2 consecutive days to induce experimental MI. At the end of experiment, the effects of catalpol on cardiac function; apelin levels; apoptosis index; apelin, APJ, Bcl-2, and Bax protein expression; and caspase-3/9 activities were investigated.
Results: The rats in the ISO group showed lower left ventricular maximum rate of positive or negative pressure development (±LVdp/dtmax) and left ventricular end-systolic pressure (LVSP) and higher left ventricular end-diastolic pressure (LVEDP) than those in the control group, suggesting severe cardiac dysfunction. Interestingly, catalpol administration significantly ameliorated the ISO-induced cardiac dysfunction. The groups administered low and high dosages catalpol (5 and 10 mg/kg/day, respectively) showed higher ±LVdp/dtmax and LVSP and lower LVEDP than the group administered ISO alone. Catalpol markedly upregulated apelin levels in the plasma and myocardium. Further, catalpol increased the apelin and APJ expression levels in the myocardium of the ISO-treated rats. In addition, catalpol pretreatment inhibited cardiomyocyte apoptosis as indicated by a decrease in the TUNEL-positive cell percentage, alterations in the Bax and Bcl-2 expression levels, and a decline in caspase-3 and caspase-9 activities.
Conclusion: Our results revealed that catalpol can improve cardiac function. Its protective effects may be linked to the enhancement of myocardium contractility, regulation of the apelin/APJ pathway, and inhibition of cardiomyocyte apoptosis.

Keywords: catalpol, cardiac dysfunction, myocardial infarction, cardiomyocyte apoptosis, apelin, APJ


Fangjie Bi, Yujia Xu, Quansan Sun. Catalpol pretreatment attenuates cardiac dysfunction following myocardial infarction in rats. Anatol J Cardiol. 2018; 19(5): 296-302

Corresponding Author: Yujia Xu, China


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright © 2018 Turkish Society of Cardiology